Psychiatry and Neurology, Neurology · Tulsa, OK
NPI
1053522847
Since 2007
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
10109 E 79th St
Tulsa, OK, 74133
Phone (918) 233-9550
Groups this clinician bills Medicare through
Medicare paid, 2024
$182K
4,800 services
Medicare patients, 2024
167
Average age 68
Drug cost, 2024
$2.9M
1,761 prescriptions
Company payments, 2025
$0
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Aimee P Borazanci was code 99214 (office e&m - established), 132 times for 105 patients. In total Aimee P Borazanci billed 4,800 services in 29 codes, and Medicare paid $182K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-06-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 132 | 105 | $84.49 | $11K |
| 99232 Hospital E&M - Subsequent | Facility | 47 | 18 | $60.62 | $2,849 |
| 96375 Injection Administration | Office | 25 | 12 | $10.40 | $260 |
| 96366 Intravenous Infusion, Hydration | Office | 20 | 11 | $12.59 | $252 |
| 99205 Office E&M - New | Office | 19 | 19 | $157.04 | $2,984 |
| 96365 Intravenous Infusion, Hydration | Office | 12 | 12 | $40.19 | $482 |
By year: 2022 $395K for 11,257 services; 2023 $457K for 11,445 services; 2024 $182K for 4,800 services.
Medicare prescription drug claims, 2024
In 2024, the drug Aimee P Borazanci prescribed most often to Medicare patients was Baclofen, with 265 prescriptions and refills. In total Aimee P Borazanci wrote 1,761 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Baclofen Generic | 265 | 456 | 65 | $6,071 |
| Dalfampridine Er Dalfampridine | 164 | 195 | 25 | $44K |
| Gabapentin Generic | 146 | 236 | 30 | $2,801 |
| Modafinil Generic | 104 | 125 | 21 | $5,683 |
| Pregabalin Generic | 75 | 87 | 11 | $3,523 |
| Copaxone Glatiramer Acetate | 68 | 72 | Under 11 | $416K |
| Kesimpta Pen Ofatumumab | 59 | 59 | Under 11 | $608K |
| Nuedexta Dextromethorphan Hbr/Quinidine | 52 | 58 | Under 11 | $88K |
| Aubagio Teriflunomide | 46 | 46 | Under 11 | $428K |
| Ampyra Dalfampridine | 46 | 46 | Under 11 | $195K |
| Duloxetine Hcl Generic | 42 | 69 | Under 11 | $935 |
| Diazepam Generic | 37 | 37 | 19 | $370 |
| Dimethyl Fumarate Generic | 35 | 35 | Under 11 | $21K |
| Fingolimod Fingolimod Hcl | 31 | 31 | Under 11 | $6,615 |
| Teriflunomide Generic | 30 | 36 | Under 11 | $22K |
Brand drugs: 371 claims; generic drugs: 1,390 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Aimee P Borazanci $0 (- in general payments such as food, travel and fees) from 2 companies.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.